[Severe bronchial asthma patient care organization in various regions of the Russian Federation. From endotypes and phenotypes of bronchial asthma to personalized choice of therapy].

Avdeev, S N; Volkova, O A; Demko, I V; Ignatova, G L; Leshchenko, I V; Kanukova, N A; Kudelya, L M; Nevzorova, V A; Nedashkovskaya, N G; Ukhanova, O P; Shulzhenko, L V; Fassakhov, R S

Avdeev, S N; Volkova, O A; Demko, I V; Ignatova, G L; Leshchenko, I V; Kanukova, N A; Kudelya, L M; Nevzorova, V A; Nedashkovskaya, N G; Ukhanova, O P; Shulzhenko, L V; Fassakhov, R S.

Afiliação

Avdeev SN; Sechenov First Moscow State Medical University (Sechenov University).
Volkova OA; City Clinical Hospital No.6.
Demko IV; Voyno-Yasenetsky Krasnoyarsk State Medical University.
Ignatova GL; South Ural State Medical University.
Leshchenko IV; Ural State Medical University.
Kanukova NA; Stavropol Regional Clinical Consultative and Diagnostic Center.
Kudelya LM; Novosibirsk State Medical University.
Nevzorova VA; Pacific State Medical University.
Nedashkovskaya NG; Regional Clinical Hospital No.2.
Ukhanova OP; Stavropol State Medical University.
Shulzhenko LV; Kuban State Medical University.
Fassakhov RS; Kazan (Volga) Federal University.

Ter Arkh ; 92(2): 119-123, 2020 Apr 27.

Article em Ru | MEDLINE | ID: mdl-32598729

Assuntos

Asma; Humanos; Moscou; Assistência ao Paciente; Fenótipo; Federação Russa

Palavras-chave

T2-bronchial asthma; benilizumab; biological therapy of bronchial asthma; dupilumab; endotype; mepolizumab; omalizumab; phenotype; resilizumab; severe bronchial asthma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma Tipo de estudo: Guideline Limite: Humans País como assunto: Asia / Europa Idioma: Ru Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google